MasTec, Inc. (MTZ) Tops Q4 EPS by 1c; Guides Q1, FY12
Tweet
Share
E-mailGet Alerts MTZ Hot Sheet
Price: $362.97 +1.25%
Revenue Growth %: +22.6%
Financial Fact:
Basic net income per share attributable to MasTec: 0.7
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: +22.6%
Financial Fact:
Basic net income per share attributable to MasTec: 0.7
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
MasTec, Inc. (NYSE: MTZ) reported Q4 EPS of $0.15, $0.01 better than the analyst estimate of $0.14. Revenue for the quarter came in at $774.2 million versus the consensus estimate of $680.63 million.
MasTec, Inc. sees Q1 2012 EPS of $0.15-$0.17, versus the consensus of $0.17. MasTec, Inc. sees Q1 2012 revenue of $725 million, versus the consensus of $660.8 million.
MasTec, Inc. sees FY2012 EPS of $1.42, versus the consensus of $1.42. MasTec, Inc. sees FY2012 revenue of $3.25 billion, versus the consensus of $3.21 billion.
For earnings history and earnings-related data on MasTec, Inc. (MTZ) click here.
MasTec, Inc. sees Q1 2012 EPS of $0.15-$0.17, versus the consensus of $0.17. MasTec, Inc. sees Q1 2012 revenue of $725 million, versus the consensus of $660.8 million.
MasTec, Inc. sees FY2012 EPS of $1.42, versus the consensus of $1.42. MasTec, Inc. sees FY2012 revenue of $3.25 billion, versus the consensus of $3.21 billion.
For earnings history and earnings-related data on MasTec, Inc. (MTZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- Medtronic completes $550 million Scientia Vascular acquisition
- RH (RH) Tops Q1 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
